International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 2
March-April 2026
Indexing Partners
Choosing the Right Probiotic for the Right Child: A Comprehensive, Evidence-Based Review for Pediatric Practice
| Author(s) | Dr. venugopal Reddy Iragamreddy |
|---|---|
| Country | India |
| Abstract | Background: Probiotics are widely used in pediatrics, yet decisions are confounded by strain heterogeneity, mixed evidence, and variable product quality. Objective: To present a clinician-friendly, strain-specific, indication-first review for use from the newborn period through adolescence, with an India-specific brand–strain mapping. Methods: Narrative synthesis emphasizing ESPGHAN position guidance, Cochrane reviews, major multicenter RCTs in acute gastroenteritis, pediatric data for infantile colic and Helicobacter pylori adjunct therapy, and safety communications from AAP and regulators. Key findings: Antibiotic-associated diarrhea (AAD) prevention has the strongest pediatric evidence with Lactobacillus rhamnosus GG (LGG, ATCC 53103) and Saccharomyces boulardii CNCM I-745. Acute gastroenteritis (AGE) treatment with common lactobacilli showed no benefit in two large NEJM RCTs; regional guidance is cautious. Infantile colic demonstrates consistent benefit with Limosilactobacillus reuteri DSM 17938 (especially in exclusively breast-fed infants). URTI prevention shows modest, strain-heterogeneous effects. Dental/ENT uses (halitosis, gingival indices) have supportive evidence for Streptococcus salivarius K12/M18 as adjuncts to hygiene. Bacillus clausii has pragmatic utility as an acute diarrhea adjunct (India). Preterm/VLBW infants: routine use not recommended by AAP; FDA warns of invasive infection risk. Conclusion: Use an S-D-D-I framework—Strain, Dose, Duration, Indication—prioritizing products with documented strain codes and quality. |
| Keywords | probiotics; pediatrics; antibiotic-associated diarrhea; acute gastroenteritis; infantile colic; URTI; halitosis; dental; India brands; safety |
| Field | Medical / Pharmacy |
| Published In | Volume 7, Issue 5, September-October 2025 |
| Published On | 2025-09-13 |
| DOI | https://doi.org/10.36948/ijfmr.2025.v07i05.55756 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals